| About the author: |
O. I. Vynnychenko, R. Y. Lakhtaryna, Y. V. Moskalenko |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Breast cancer occupies the second place in the structure of morbidity and the fourth place in the structure of mortality among all cancer types. To study the epidemiology of breast cancer, we used data from the National Cancer Registry of Ukraine and the Global Cancer Observatory. From 2014 to 2019, morbidity and mortality rates in Ukraine and the Sumy region were stable. Since 2020, there has been a significant deviation in incidence rates and a rapid decrease in mortality from breast cancer. The most significant decrease in incidence was observed in 2020 and 2022. In 2023, this trend continued. In comparison with Ukraine, the morbidity in the USA is more than twice as high, but the mortality rates are almost the same. In China, the incidence of breast cancer is lower than in Ukraine, but it tends to increase. The decrease in morbidity and mortality in Ukraine cannot be considered an improvement in the epidemiological situation. It is almost impossible to establish accurate data during the war. |
| Tags |
breast cancer,morbidity,mortality,Ukraine,Sumy region |
| Bibliography |
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. doi:10.3322/caac.21492.
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229–263. doi: 10.3322/caac.21834.
- Chlebowski RT, Aragaki AK. Long-term breast cancer incidence trends by mammography, obesity, and menopausal hormone therapy. Breast Cancer Res Treat. 2024 Jan;203(1):121–124. doi: 10.1007/s10549-023-07113-9.
- Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020 Aug;8(8): e1027-e1037. doi: 10.1016/S2214-109X(20)30215-1.
- Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, et al. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. Biomed Res Int. 2022 Apr 18; 2022:9605439. doi: 10.1155/2022/9605439. Retraction in: Biomed Res Int. 2023 Dec 29; 2023:9872034. doi: 10.1155/2023/9872034.
- Kozhukhov S, Dovganych N, Smolanka I, Kryachok I, Kovalyov O. Cancer and War in Ukraine: How the World Can Help Win This Battle. JACC CardioOncol. 2022 Apr 12;4(2):279–282. doi: 10.1016/j.jaccao.2022.04.001.
- Nabok AI. Prevalence and incidence of breast cancer in Ukraine. Wiad Lek. 2023;76(10):2219–2223. doi: 10.36740/WLek202310114.
- Nikitenko R, Kosovan V, Vorotyntseva K, Koichev E, Degtyarenko S, Kvasha O. et al. Improvement of the algorithm of intraoperative diagnosis of breast cancer metastasis using sentinel lymph node staining. World of medicine and biology. 2023;1(83): 143–147. doi: 10.26724/2079-8334-2023-1-83-143-147
- Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J et al. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncol. 2023 Jan;24(1):22–32. doi: 10.1016/S1470-2045(22)00704-5.
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–249. doi:10.3322/caac.21660.
- Tao X, Li T, Gandomkar Z, Brennan PC, Reed WM. Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries. Asia Pac J Clin Oncol. 2023 Dec;19(6):645–654. doi: 10.1111/ajco.13958.
- Terry MB, Colditz GA. Epidemiology and Risk Factors for Breast Cancer: 21st Century Advances, Gaps to Address through Interdisciplinary Science. Cold Spring Harb Perspect Med. 2023 Sep 1;13(9): a041317. doi: 10.1101/cshperspect.a041317.
- Tolia M, Kamposioras K, Symvoulakis EK, Mauri D, Skouras P, Schizas D, et al. Cancer patient care during different war times; is the response too slow? ESMO Open. 2022 Aug;7(4):100557. doi: 10.1016/j.esmoop.2022.100557.
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar;65(2):87–108. doi: 10.3322/caac.21262.
- Vynnychenko OI, Moskalenko YV. Prognostic impact of body mass index on metastatic HER2-positive breast cancer survival. Ukrainian journal of radiology and oncology. 2024;32(3):363–376. doi: https://doi.org/10.46879/ukroj.3.2024.363-376c.
|
| Publication of the article |
«World of Medicine and Biology» №4(90), 2024 year, 030-033 pages, index UDK 618.19-006-036.8(477.52) |
| DOI |
10.26724/2079-8334-2024-4-90-30-33 |
